Kevin Craig is a senior medical director in Early Clinical Medical and Scientific Services at Covance. Prior to 2017, he worked in the late-stage neuroscience group. Prior to joining Covance in 2011, Dr Craig worked with a pharmaceutical consortium to develop and commercialize translational biomarkers for the prediction of drug efficacy in early human trials. Kevin holds a MBBCh from University of the Witwatersrand and an MPhil degree from the University of Cambridge, UK.